Selective rather than blanket: How the treatment of interleukin-6-driven diseases can be refined Researchers in Kiel show in Nature Reviews Drug Discovery how the harmful side of interleukin-6 can be blocked without switching off its protective ... weiterlesen

Show Post

🔬 𝐖𝐡𝐞𝐫𝐞 𝐚𝐜𝐚𝐝𝐞𝐦𝐢𝐚 𝐦𝐞𝐞𝐭𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: 𝐞𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 "𝐓𝐚𝐫𝐠𝐞𝐭𝐞𝐝 𝐃𝐫𝐮𝐠 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲" – 𝐑𝐞𝐠𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 𝐎𝐩𝐞𝐧𝐬 𝐒𝐞𝐩𝐭𝐞𝐦𝐛𝐞𝐫 28 💡 A unique mix of academic research and industrial expertise, brings together experts from leading research institutions and companies for exchange. 👉 tdd.gbm-online.de/home.html

Show Post

The tetanus vaccine was introduced into the UK’s routine infant immunisation programme in 1961. By the 1970s, tetanus in UK children under 15 had almost disappeared. Between 1985 and 2017, there were no cases in children under five. Read the story: vist.ly/5idxc

Show Post

🌟 Women Shaping #STEM: Stories, Careers, Conversations 🌟 Join us for an inspiring talk by @julianeg.bsky.social, MPI-IE Group Leader, as she shares the personal story behind her career. 📅 Wed, Sept 16 | 11-12 AM 📍 Lecture Hall, MPI-IE, Freiburg Register via @cibss.bsky.social: s.gwdg.de/iMivMZ

Show Post

🥳 Congratulations to our Emeritus Director Thomas Boehm on receiving the Emory Max Cooper Prize in Immunology 2026! He gets gets honored for his pioneering work in evolutionary immunology and shares the prize with Klaus Rajewsky (Berlin) and Tadatsugu Taniguchi (Tokyo). s.gwdg.de/Rguoy6

Show Post